Last updated on October 2018

A Multi-center Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects.

Brief description of study

This voluntary study is testing an investigational medicine, called IDP-124, to see if it is safe to use on individuals 12 and older who have Moderate to Severe Atopic Dermatitis.


If you are able to be in the study, you, your parent(s) or your legal guardian will be told how to apply the study lotion to your eczema.  You, your parent, or your legal guardian will apply the study lotion twice a day, around the same time each day, to the areas with eczema on your body.  You should wait about 12 hours in between each application.  You will do this every day for 6 weeks.  There is a final visit 4 weeks later.  The study doctor will check you and your eczema to see how you are doing. During the 4 weeks until the final visit, you will not be using any study lotion.  If you are able to be on the study you may have to stop your regular eczema medications. In addition, you can only use some types of lotions or creams, soaps, sunscreens, and make-up.  Your study doctor will provide you with approved creams you can use.  Talk to the study doctor about this.

Study visits include Screening, Baseline, and Weeks 1, 2, 4, 6, and 10 (Patients will return to the clinic at Week 10 for a post-treatment follow-up visit).


Clinical Study Identifier: TX213554

Find a site near you

Start Over

Center for Clinical Studies, LTD. LLP.

1401 Binz Street, STE 200 Houston, TX United States
  Connect »